… Several cytokines have great therapeutic potential, and some are currently being tested as
therapeutic targets in clinical trials for the treatment of liver diseases, which are also described…

… cytokines to stimulate liver regeneration. Similarly, G-CSF improves the function of normal
and dysfunctional granulocytes, which also secrete cytokines to stimulate liver … against liver …

… Non-alcoholic fatty liver disease (NAFLD) is an unmet … clinical data on adipokines, cytokine-like
hormones secreted by … , as well as their potential as therapeutic targets for NAFLD. The …

… virus infection, alcoholic liver disease, nonalcoholic fatty liver disease, autoimmune … of
hepatic innate lymphocytes will be helpful for proposing effective treatments for liver diseases and …

… liver disease, liver fibrosis, cirrhosis, liver failure, and liver … review summarizes the role of
neutrophils in liver diseases. … During liver cirrhosis, high levels of proinflammatory cytokines…

… MMPs in liver diseases. MMP expression patterns in different stages of liver diseases have
also … , we highlight MMPs as promising therapeutic targets for the resolution of liver diseases. …

… the regulation and function of miRNAs in liver diseases with a major focus on miRNAs that
… diseases and may identify biomarkers and therapeutic targets for liver diseases in the future…

… targets for treating chronic liver diseases, including … liver and causes hepatocyte damage,
resulting in the activation of Kuffer cells (KCs) and the overproduction of inflammatory cytokines…

… stress, promote inflammation, cell death, and progressive liver damage. These hits activate
inflammatory cascades and pro-inflammatory cytokines, including interleukin (IL)-1β, tumor …

… modulators of these pathways for the treatment of cholestatic and autoimmune liver diseases.
… Unlike in hepatocytes, bile acid–induced cytokine secretion was not observed in liver non-…